Roy S. Herbst received an award of appreciation by the SWOG Cancer Research Network for his passion, commitment, leadership, and enduring dedicated service to the ground-breaking Lung-MAP protocol. The award was given at a commemorative dinner during the SWOG Annual Meeting.
Brad Diephuis was named chief business officer of Thyme Care, an oncology care management solution providing tech-enabled cancer care navigation (The Cancer Letter, Oct. 7, 2022).
The Houston Astros beat the New York Yankees in the American League Championship Series, settling a Twitter bet between MD Anderson and Memorial Sloan Kettering’s presidents Peter W.T. Pisters and Selwyn M. Vickers.
Selina M. Luger, a hematologist-oncologist and acute leukemia and myeloid disorders researcher, was appointed chair of the ECOG-ACRIN Cancer Research Group Leukemia Committee.
The James P. Allison Institute at MD Anderson Cancer Center established an internal advisory council to provide scientific input and to align the work of the institute with the broader MD Anderson research enterprise.
Fox Chase Cancer Center and Weill Cornell Medicine were selected to develop a new Cancer Prevention-Interception Targeted Agent Discovery Program.
Candel Therapeutics Inc., a clinical-stage biopharmaceutical company developing viral immunotherapies, formed a collaboration with the University of Pennsylvania to study the impact of novel viral immunotherapies based on Candel’s proprietary enLIGHTEN Discovery Platform to strengthen the effects of Penn’s CAR-T cell therapies in solid tumor models.
The Max Foundation, the ABC Global Alliance, the American Society of Clinical Pathology, Cepheid, and Novartis AG are joining and committing resources to improve outcomes for people living with HR+/HER2- advanced breast care in low- and middle-income countries.
Oksana Leontyeva, an expert in hematologic malignancies, was killed in a Russian rocket attack as she was rushing through central Kyiv to take care of her patients at OKHMATDYT, the biggest children’s hospital in Ukraine.
Sudhir Srivastava won the Don Listwin Award for Outstanding Contribution to Cancer Early Detection.
